of all car-t cell trials registered since 2001, more than half are being conducted in china.
.
comments
.
.
.
.
.: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies."